Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bristol-Myers Squibb Company (BMY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 86,637,176
  • Shares Outstanding, K 1,632,200
  • Annual Sales, $ 20,776 M
  • Annual Income, $ 1,007 M
  • 36-Month Beta 1.11
  • Price/Sales 4.18
  • Price/Cash Flow 14.79
  • Price/Book 6.18

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 0.84
  • Number of Estimates 6
  • High Estimate 0.85
  • Low Estimate 0.81
  • Prior Year 0.68
  • Growth Rate Est. (year over year) +23.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
49.86 +6.46%
on 11/27/18
54.81 -3.16%
on 11/16/18
+0.09 (+0.17%)
since 11/07/18
3-Month
46.94 +13.08%
on 10/25/18
63.69 -16.66%
on 10/09/18
-8.23 (-13.42%)
since 09/07/18
52-Week
46.94 +13.08%
on 10/25/18
70.05 -24.23%
on 02/16/18
-8.76 (-14.17%)
since 12/07/17

Most Recent Stories

More News
Bristol-Myers Squibb (BMY) Stock Moves -0.32%: What You Should Know

Bristol-Myers Squibb (BMY) closed the most recent trading day at $53.08, moving -0.32% from the previous trading session.

BMY : 53.08 (-0.32%)
Mallinckrodt (MNK) to Separate Generics & Branded Businesses

Mallinckrodt (MNK) announces plans to split its generic and branded businesses into two different companies.

MRK : 76.72 (-2.11%)
LLY : 113.58 (-1.95%)
MNK : 20.76 (-3.58%)
BMY : 53.08 (-0.32%)
Corelogic Inc Has Returned 24.8% Since SmarTrend Recommendation (CLGX)

SmarTrend identified a Downtrend for Corelogic Inc (NYSE:CLGX) on July 26th, 2018 at $51.30. In approximately 4 months, Corelogic Inc has returned 24.83% as of today's recent price of $38.56.

CTT : 8.07 (-2.18%)
EPAY : 50.20 (-1.93%)
EXAS : 71.70 (-4.30%)
WYNN : 104.99 (-6.60%)
HMSY : 33.86 (-1.83%)
GLT : 11.83 (-0.34%)
MHK : 120.44 (-2.09%)
BBW : 5.00 (-4.58%)
CDW : 91.48 (-4.25%)
COUP : 60.11 (-9.10%)
QTWO : 49.06 (-4.37%)
DENN : 16.11 (-1.53%)
MYL : 30.55 (-4.05%)
DFRG : 7.33 (-7.22%)
GCAP : 7.30 (+0.69%)
FEYE : 19.43 (-3.86%)
MXIM : 52.90 (-2.90%)
POL : 30.89 (-2.52%)
AN : 34.57 (-1.90%)
TWO : 14.43 (-0.07%)
HUBG : 40.29 (-4.50%)
AR : 12.75 (-0.23%)
RE : 228.87 (+1.52%)
NNBR : 6.75 (+0.15%)
ARE : 126.17 (-0.72%)
CVI : 37.66 (-2.76%)
CERS : 5.35 (-3.95%)
NDAQ : 87.36 (-2.81%)
ELLI : 64.18 (-3.46%)
BLDR : 12.04 (-3.64%)
EGRX : 43.90 (-6.85%)
RGLD : 78.44 (+2.80%)
PRGO : 59.93 (-4.30%)
PENN : 22.58 (-1.35%)
NTAP : 64.39 (-5.97%)
IBM : 119.34 (-3.69%)
NTRI : 34.20 (-3.01%)
BANR : 58.21 (+1.77%)
CWT : 45.91 (+1.37%)
STAA : 33.89 (-5.34%)
ATHN : 133.16 (+0.08%)
CL : 62.71 (-0.82%)
TFSL : 16.23 (+0.06%)
UFPI : 27.07 (+0.74%)
SDRL : 14.11 (+4.06%)
GOV : 8.57 (-2.17%)
HQY : 68.38 (-7.63%)
IPGP : 124.35 (-5.35%)
MINI : 34.52 (-4.90%)
CMTL : 28.44 (+11.97%)
CHD : 66.81 (+0.13%)
GPI : 52.48 (-1.58%)
HRL : 44.34 (-1.34%)
RARE : 46.66 (-7.59%)
MLI : 22.49 (-2.30%)
GPS : 26.99 (-2.25%)
CHS : 5.80 (-2.36%)
RYAM : 13.52 (-2.17%)
PBI : 7.09 (-3.93%)
NUVA : 56.12 (-3.01%)
IMDZ : 2.01 (+9.24%)
CAMP : 17.21 (-2.55%)
NOC : 257.54 (+0.21%)
AEL : 30.72 (-0.97%)
EBIX : 47.14 (+0.53%)
DISCA : 28.93 (-0.75%)
GPOR : 9.32 (+1.53%)
BGS : 29.79 (-0.10%)
TECH : 156.22 (-2.66%)
PCH : 35.48 (-5.49%)
NOV : 29.81 (-1.52%)
TECD : 83.91 (-2.28%)
DISCK : 26.90 (-0.33%)
DECK : 120.41 (-5.94%)
NOW : 182.38 (-2.78%)
MGLN : 57.63 (+3.86%)
IEX : 133.64 (-1.04%)
PTC : 83.78 (-4.27%)
AVT : 41.99 (-2.30%)
RGS : 16.45 (-3.80%)
BSFT : 54.95 (+0.09%)
FOSL : 17.58 (-6.24%)
WAL : 41.29 (-2.02%)
IVR : 15.58 (-0.19%)
ENR : 46.00 (-0.28%)
ISBC : 11.75 (-1.92%)
SHOO : 29.09 (-3.68%)
HDP : 15.94 (-6.62%)
AWK : 97.80 (+0.49%)
OMED : 0.98 (-3.92%)
LADR : 17.22 (-4.07%)
BIG : 31.00 (-23.08%)
WY : 25.27 (-5.50%)
JBLU : 17.89 (-5.09%)
GNMK : 5.03 (-2.52%)
FORM : 14.95 (-3.24%)
PFSI : 22.27 (+2.86%)
NEWM : 12.75 (-0.08%)
KFRC : 29.50 (-2.16%)
HOLX : 41.98 (-2.94%)
TMK : 80.25 (-0.93%)
AXTA : 23.79 (-3.33%)
PGEM : 21.65 (unch)
CLH : 57.51 (-4.18%)
CLI : 21.64 (-1.01%)
NRG : 40.53 (-0.07%)
CLGX : 38.16 (-2.05%)
SFLY : 46.01 (-3.72%)
ICUI : 231.94 (-2.65%)
CARA : 16.07 (-6.02%)
WTR : 35.39 (+1.06%)
NTGR : 52.50 (+2.06%)
OLED : 95.38 (-3.26%)
VNDA : 27.60 (-6.19%)
HIBB : 15.52 (-1.27%)
FFBC : 26.20 (+1.12%)
DLTR : 83.39 (-3.32%)
EQT : 18.41 (+2.33%)
OMER : 14.02 (-1.82%)
KTOS : 13.64 (-0.73%)
SRCL : 43.93 (-2.77%)
GES : 21.84 (-5.45%)
KMX : 62.56 (-3.04%)
PLAB : 9.06 (-4.93%)
NCS : 10.49 (-2.96%)
MAR : 111.25 (-3.53%)
MRVL : 15.44 (-4.04%)
UAL : 88.23 (-5.16%)
CNK : 38.93 (-1.77%)
NATH : 70.78 (+4.55%)
TPH : 12.16 (-1.86%)
OCUL : 5.82 (-4.12%)
SKYW : 49.79 (-5.77%)
HIVE : 3.43 (-4.19%)
GAIA : 11.56 (-5.94%)
ESRX : 95.85 (-2.17%)
PHM : 26.23 (-1.58%)
EBS : 65.59 (-5.29%)
CACI : 157.17 (-1.15%)
SAVE : 59.67 (-7.62%)
EZPW : 8.73 (-2.02%)
TPX : 49.91 (-3.91%)
KLAC : 92.19 (-3.53%)
ULTA : 254.47 (-13.13%)
WWE : 75.05 (-1.99%)
ESV : 5.11 (-0.78%)
LTRPA : 18.59 (-4.72%)
DAL : 56.07 (-3.46%)
BMY : 53.08 (-0.32%)
ECL : 154.07 (-2.21%)
CHRW : 87.69 (-2.62%)
WWW : 33.06 (-3.16%)
ETH : 19.69 (-1.94%)
IART : 49.96 (-2.02%)
LE : 15.08 (-15.90%)
LH : 141.96 (-1.14%)
HZO : 19.86 (-5.47%)
MTD : 590.78 (-3.17%)
OSTK : 17.37 (-9.20%)
LDOS : 58.87 (-2.31%)
SAGE : 102.68 (-3.02%)
CIEN : 31.28 (-2.98%)
MTW : 16.14 (-4.38%)
AMC : 14.27 (-2.46%)
NDLS : 7.44 (-3.50%)
EFII : 25.78 (-5.26%)
SIVB : 205.80 (-6.09%)
MU : 35.31 (-6.26%)
DSW : 24.21 (-4.72%)
VRNT : 45.02 (-1.77%)
OII : 15.59 (-0.95%)
SAFM : 103.30 (-3.09%)
DATA : 123.43 (-3.55%)
TLYS : 11.47 (+2.14%)
TREE : 242.74 (-7.32%)
TRUP : 26.63 (-6.00%)
AMCX : 58.06 (-0.21%)
EXPD : 70.57 (-5.02%)
SUPN : 36.53 (-9.89%)
NBIX : 84.18 (-3.21%)
SAIC : 69.40 (+6.87%)
CBM : 45.27 (-3.02%)
BURL : 157.79 (-5.83%)
AMED : 130.30 (-3.82%)
EXPR : 5.84 (-5.65%)
SBH : 19.29 (-2.43%)
ATSG : 17.79 (-1.55%)
PLT : 39.79 (-3.07%)
QDEL : 48.73 (-20.53%)
NLNK : 1.83 (-0.54%)
STMP : 171.71 (-2.75%)
IPCC : 142.80 (+0.32%)
BMTC : 36.38 (+2.05%)
STML : 9.98 (-1.87%)
EGL : 31.08 (+4.82%)
LUV : 51.36 (-4.18%)
CCL : 56.73 (-3.68%)
INOV : 13.05 (+3.08%)
COTY : 7.50 (-2.22%)
MGM : 25.99 (-5.22%)
AKBA : 8.53 (unch)
LGIH : 44.41 (+0.66%)
CDNS : 42.67 (-3.02%)
CRZO : 15.90 (-2.81%)
TEN : 30.16 (-4.38%)
HAIN : 19.30 (-3.11%)
Novartis Presents Additional Data on Breast Cancer Candidate

Novartis (NVS) presents supplementary data from phase III study on BYL719 in combination with Faslodex for the treatment of advanced breast cancer. The study scripts success in PFS.

AZN : 38.18 (-1.78%)
MRK : 76.72 (-2.11%)
NVS : 87.08 (-2.21%)
BMY : 53.08 (-0.32%)
AstraZeneca's Imfinzi Fails in Head and Neck Cancer Study

AstraZeneca's (AZN) Imfinzi monotherapy and combination therapy fail to meet overall survival endpoint in phase III EAGLE study.

AZN : 38.18 (-1.78%)
MRK : 76.72 (-2.11%)
INCY : 64.51 (-0.91%)
BMY : 53.08 (-0.32%)
Bristol-Myers Squibb Announces Dividend Increase

The Board of Directors of Bristol-Myers Squibb Company (NYSE:BMY) today declared an increase of 2.5% percent in the company's quarterly dividend, beginning in the first quarter of ...

BMY : 53.08 (-0.32%)
Roche's Tecentriq Combination Gets Priority Review by FDA

The FDA accepts and grants Priority Review to Roche's (RHHBY) sBLA for Tecentriq in combination with carboplatin and etoposide for the initial treatment of patients withextensive-stage small cell lung...

NVS : 87.08 (-2.21%)
RHHBY : 31.5000 (-0.54%)
AMGN : 191.44 (-3.80%)
BMY : 53.08 (-0.32%)
Bristol-Myers Squibb to Announce Results for Fourth Quarter 2018 on January 24

Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the fourth quarter of 2018 on Thursday, January 24, 2019. During a conference call at 10:30 a.m. ET on January 24,...

BMY : 53.08 (-0.32%)
J&J Strikes Deal with argenx to Co-Develop Cancer Antibody

Johnson & Johnson (JNJ) inks a global deal with Europe's argenx to jointly develop and globally commercialize the latter's prospective antibody, cusatuzumab.

CELG : 70.08 (-3.74%)
ARWR : 13.13 (-3.67%)
JNJ : 145.43 (-0.33%)
BMY : 53.08 (-0.32%)
Roche Announces Positive Data on Venclexta/Venclyxto at ASH

Roche (RHHBY) announces new Venclexta/Venclyxto data that demonstrate deep responses in two of the most common types of leukaemia.

ABBV : 86.96 (-3.73%)
TEVA : 19.41 (-4.20%)
RHHBY : 31.5000 (-0.54%)
BMY : 53.08 (-0.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade BMY with:

Business Summary

Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious...

See More

Key Turning Points

2nd Resistance Point 54.26
1st Resistance Point 53.67
Last Price 53.08
1st Support Level 52.62
2nd Support Level 52.16

See More

52-Week High 70.05
Fibonacci 61.8% 61.22
Fibonacci 50% 58.50
Fibonacci 38.2% 55.77
Last Price 53.08
52-Week Low 46.94

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar